Sustained meticillin-resistant Staphylococcus aureus control in a hyper-endemic tertiary acute care hospital with

D Fisher1, P A Tambyah, R T P Lin

  • 1Department of Medicine, National University Health System, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Infection Control Team, National University Health System, Singapore.

Abstract

Insights

A hospital implemented a Meticillin-resistant Staphylococcus aureus (MRSA) control bundle, significantly reducing MRSA infections and bacteraemia. Hand hygiene compliance improved substantially, demonstrating a sustainable model for infection prevention in hyper-endemic settings.

Area of Science:

  • Infectious Disease Epidemiology
  • Hospital Infection Control
  • Public Health

Background:

  • Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in Singapore hospitals, causing over 600 infections annually.
  • A 995-bed university hospital utilized approximately 5% of beds for isolation facilities.

Purpose of the Study:

  • To evaluate the impact of a phased MRSA control bundle implementation.
  • To assess the bundle's effectiveness across hospital wards using gradual geographic extension.

Main Methods:

  • Implemented a bundle including active surveillance, isolation, cohorting, enhanced hand hygiene, and public feedback.
  • Utilized interrupted time-series analysis to evaluate results from October 2006 to June 2010.

Main Results:

  • MRSA bacteraemia decreased from 0.26 to 0.11 cases per 1000 inpatient-days between 2004 and 2012.
  • MRSA acquisition rates declined a year post-implementation; hand hygiene compliance rose from 47% to 69% between 2009 and 2012.

Conclusions:

  • Staged implementation of the MRSA bundle is sustainable in hyper-endemic hospital settings.
  • This model offers a transferable strategy for infection control in similar environments.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Methods for Controlling Microbial Growth01:29

Methods for Controlling Microbial Growth

Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...